🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

58 results for “dexmedetomidine” Clear

  1. Dexmedetomidine

    First Tracks Biotherapeutics

    Overall Survival

    approved small molecule completed

    1 trial

  2. Dexmedetomidine

    BioXcel Therapeutics

    Schizophrenia Agitation

    approved small molecule active

    1 trial

  3. Dexmedetomidine

    First Tracks Biotherapeutics

    Postoperative Delirium After Living Donor Renal Transplantation

    approved small molecule active

    1 trial

  4. Dexmedetomidine

    United Therapeutics Europe Ltd

    Breast Cancer

    approved small molecule active

    1 trial

  5. Dexmedetomidine

    First Tracks Biotherapeutics

    Renal Function

    approved small molecule active

    1 trial

  6. Dexmedetomidine Group

    China SXT Pharmaceuticals

    Lung Cancer

    approved small molecule completed

    1 trial

  7. Dexmedetomidine Injectable Solution

    China SXT Pharmaceuticals

    Epilepsy

    approved small molecule completed

    1 trial

  8. Dexmedetomidine-esketamine combination

    First Tracks Biotherapeutics

    Obstructive Sleep Apnea

    approved small molecule active

    1 trial

  9. Esketamine combined with dexmedetomidine

    First Tracks Biotherapeutics

    Dexmedetomidine

    approved small molecule active

    2 trials

  10. Intranasal dexmedetomidine-esketamine

    First Tracks Biotherapeutics

    Adenotonsillectomy

    approved small molecule active

    1 trial

  11. dexmedetomidine

    First Tracks Biotherapeutics

    Aged

    approved small molecule completed

    3 trials

  12. dexmedetomidine

    China SXT Pharmaceuticals

    Sleep Quality of Patients Undergoing TURP

    approved small molecule completed

    1 trial

  13. dexmedetomidine

    First Tracks Biotherapeutics

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial

  14. dexmedetomidine hydrochloride for injection

    First Tracks Biotherapeutics

    Delirium

    approved small molecule completed

    1 trial

  15. Dexmedetomidine

    First Tracks Biotherapeutics

    Old Age

    small molecule terminated

    1 trial

  16. Dexmedetomidine

    United Therapeutics Europe Ltd

    Dexmedetomidine

    small molecule active

    1 trial

  17. Dexmedetomidine

    First Tracks Biotherapeutics

    Anxiety

    small molecule completed

    1 trial

  18. Dexmedetomidine

    First Tracks Biotherapeutics

    Benign Neoplasm of Vocal Fold - Glottis

    small molecule completed

    1 trial

  19. Dexmedetomidine

    First Tracks Biotherapeutics

    Renal Failure

    small molecule active

    1 trial

  20. Dexmedetomidine

    China SXT Pharmaceuticals

    Bronchoscopy

    small molecule active

    1 trial

  21. Dexmedetomidine

    China SXT Pharmaceuticals

    Cardiac Surgery

    small molecule completed

    1 trial

  22. Dexmedetomidine

    China SXT Pharmaceuticals

    Lung Cancer

    small molecule completed

    1 trial

  23. Dexmedetomidine Injection

    First Tracks Biotherapeutics

    Coronary Disease

    small molecule completed

    1 trial

  24. Dexmedetomidine Injection (nasal spray) + Propofol Injection + Sufentanil Injection

    China SXT Pharmaceuticals

    Dexmedetomidine Induced Sedation

    small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources